HSV PCR testing market seen reaching $1.74 billion by 2030

By AI, Created 5:26 PM UTC, May 18, 2026, /AGP/ – The global HSV PCR testing market is projected to grow from $1.18 billion in 2025 to about $1.74 billion by 2030, driven by rising infection rates, wider screening and faster molecular diagnostics. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - HSV PCR testing is a fast, sensitive tool for detecting herpes simplex virus DNA in clinical samples. - The market’s growth points to wider use of molecular diagnostics for earlier diagnosis, treatment decisions and infection control. - The expansion also signals rising demand for rapid, point-of-care testing and automated lab systems.

What happened: - The Business Research Company said the global HSV PCR testing market is expected to rise from $1.18 billion in 2025 to $1.28 billion in 2026. - The market is forecast to reach $1.74 billion by 2030. - The company projected an 8.0% CAGR from 2025 to 2026 and an 8.2% CAGR through 2030. - The announcement was dated May 15, 2026, and cited London as the release location. - The full market report is available online.

The details: - HSV PCR testing detects HSV DNA from blood, swabs and cerebrospinal fluid. - The test is used for genital, oral and neonatal HSV infections. - The company linked recent market growth to higher HSV prevalence, greater awareness of sexually transmitted infections, more molecular diagnostic labs, broader use of nucleic acid amplification tests and wider availability of antiviral treatments. - Looking ahead, growth is expected to come from routine HSV screening, demand for rapid molecular diagnostics, precision medicine in infectious disease care, higher healthcare spending in emerging markets and advances in multiplex and quantitative PCR platforms. - The report said real-time PCR, multiplex PCR assays, high-sensitivity quantitative PCR and automated sample-to-result systems are becoming more common. - North America was the largest regional market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The regional analysis also covered South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - Rising infection rates are helping drive demand for faster diagnostics across infectious diseases, not just HSV testing. - The shift toward automated and multiplex systems suggests labs are looking for higher throughput and broader panels in a single test. - The biggest growth may come from markets where screening is expanding and healthcare infrastructure is still building out.

What’s next: - More routine HSV screening and earlier neonatal and genital HSV diagnosis could lift testing volumes. - Adoption of real-time and multiplex PCR platforms may reshape competitive positioning for diagnostic providers. - The market’s next phase will likely depend on how quickly healthcare systems invest in molecular testing capacity and automation.

The bottom line: - HSV PCR testing is moving from a specialized diagnostic tool toward broader routine use, and the market is on track for steady global expansion through 2030.